Nursing Management: Diabetes Mellitus Flashcards

1
Q

Diabetes Mellitus

A

DM is a metabolic disorder characterized by the presence of hyperglycemia due to defective insulin secretion, defective insulin action or both.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The chronic hyperglycemia of diabetes is associated

A

with relatively specific long-term microvascular complications affecting the eyes, kidneys and nerves, as well as an increased risk for cardiovascular disease (CVD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prediabetes

A

Impaired glucose tolerance (IGT) or impaired fasting glucose (IFG)

FPG = 6.1 – 6.9 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of diabetes

A

Gestational diabetes

Secondary diabetes.

  • Chronic Pancreatitis
  • Cystic Fibrosis
  • Hemochromatosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metabolic Syndrome

A

A collection of risk factors that increase an individual’s chance of developing cardiovascular disease and diabetes mellitus

  • Abdominal obesity
  • Hypertension
  • Dyslipidemia
  • Insulin resistance
  • Dysglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Primary prevention for Type 2 Diabetes

A

Modifiable Risk Factors
Obesity

Physical inactivity

Unhealthy diet

Smoking

Hypertension

High cholesterol

Non-modifiable Risk Factors
Age

Family history

Ethnicity

History of gestational diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathophysiology of diabetes: Pancreas

A
  • Beta cells regulate insulin
    Insulin increases cellular uptake of glucose
  • Alpha cells regulate glucagon
    Glucagon increases release of glucose by the liver

↑ glucose → ↑ insulin & ↓ glucagon
↓ glucose → ↓ insulin & ↑ glucagon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other hormones that increase blood glucose:

A

Epinephrine
Growth hormones
Cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathophysiology of Type 1 Diabetes

A

Lack of insulin secretion

Destruction of beta-cells resulting in decreased or absent insulin secretion

Manifestations seen when 80-90% of normal beta-cell function is destroyed

Possible causes:
- Immune system disorder (genetic predisposition)
- Virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathophysiology of Type 2 Diabetes

A
  • Insulin resistance
    - Body tissues do not respond to action of insulin
    - Decreased responsiveness of beta cells to hyperglycemia ->
    desensitization
  • Decrease in ability to produce insulin
  • Inappropriate glucose production by liver
    -Not a primary factor in development of DM2
  • Alteration in production of hormones & cytokines by adipose tissue
    - Adipocytokines play role in glucose & fat metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type 1 Diabetes:

A

Typical onset at young age (< 30 years)

Cachexic appearance due to muscle and fat breakdown

Abrupt diagnosis

Often diagnosis is precipitated by an infection or stress

Insulin required for survival

Often difficult to control blood sugar levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Type 2 Diabetes:

A

Typical onset at older age, though becoming increasingly common among young people

Slow, gradual onset

Combination of genetic and lifestyle factors

Oral hypoglycemic agents or insulin may be necessary

Relatively stable blood sugar levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnosis of diabetes

A

Symptoms of diabetes plus a random plasma glucose value ≥ 11.1 mmol/L

A fasting plasma glucose (FPG) ≥ 7.0 mmol/L

A plasma glucose value in the 2-h sample (2hPG) of a 75g oral glucose tolerance test (OGTT) ≥ 11.1 mmol/L

A1C >6.5% (in adults)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Glucosylated Hemoglobin: HbA1c

A

Shows amount of glucose that has been attached to Hgb molecules, which are attached to RBC for life of cell (approx. 120 days)

Indicates overall glucose control for previous 90-120 days

All clients with diabetes should have this tested q3-6 mos.

People who can maintain near-normal A1c levels have greatly reduced risk for development of complications

Ideal is ≤ 7% for those with diabetes (normal range ≤ 6%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Impaired fasting glucose (IFG)

A

Fasting Plasma Glucose (mmol/L): 6.1 - 6.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Impaired glucose tolerance (IGT)

A

2-hr Plasma Glucose in a 75-g Oral Glucose Tolerance Test (mmol/L)

7.8 – 11.0

17
Q

Prediabetes

A

Glycated
Hemoglobin
(A1C) (%)

6.0 - 6.4

18
Q

Clinical Manifestations Type 1

A

The 3 P’s: Polyuria, Polydipsia, and Polyphagia.

Weight loss

Ketonuria & ketoacidosis:
- Fruity breath
- Nausea & Vomiting, Abdominal pain
- Very ill person

Weakness & fatigue

Visual changes

19
Q

Type 2

A

Symptoms Associated with Prolonged Hyperglycemia:
Chronic blurred vision

Recurrent infections (skin, vaginal yeast), slow-healing wounds

Neuropathic pain

Characteristics:
Gradual onset

May have “classic” manifestations

No typical weight loss; often weight gain (especially middle fat, although limbs may be thin)

Often fatigue is the only symptom

20
Q

Goals for Management of Diabetes

A

Maintain blood glucose levels within the target range

Monitor and manage cardiovascular risk factors

Control the diabetes so it does not control you!

Promote overall health through a balanced diet and regular physical activity

21
Q

ABCDESSS of Diabetes Care

A

A - A1Ctargets
B – BP Targets
C – Cholesterol Targets
D - Drugs for CV and/ or Cardiorenal protection
E – Exercise goals and healthy eating
S – Screening for complications
S – Smoking cessation
S – Self-management

22
Q

Pharmacological Management

A

Insulins:
- Rapid
- Short acting
- Intermediate acting (cloudy)
- Extended long acting
- Premixed (cloudy)

23
Q

Rapid-acting insulin analogues (clear):
Insulin aspart (NovoRapid®)
Insulin glulisine (Apidra™)
Insulin lispro (Humalog®)

A

Onset: 10 - 15 mins

peak: 1 - 1.5 hr

Duration: 3 - 5 hr

24
Q

Short-acting insulins (clear):
Insulin regular (Humulin®-R)
Insulin regular (Novolin®geToronto)

A

Onset: 30 mins

Duration: 2 - 3 hr

Duration: 6.5 hr

25
Intermediate-acting insulins (cloudy): Insulin NPH (Humulin®-N) Insulin NPH (Novolin®ge NPH)
Onset: 1 - 3 hr Peak: 5 - 8 hr Duration: 18 hr
26
Long-acting basal insulin analogues (clear) Insulin detemir (Levemir®) Insulin glargine (Lantus®) Insulin glargine U300 (Toujeo®)
Onset 90 min Up to 6 h Peak Not applicable Duration Up to 24 h (detemir 16-24 h) Up to 24 h (glargine 24 h) Up to 30 h
27
Insulin delivery
Education client regarding Timing of insulin and meals Insulin syringes and concentrations Storage Preparation Site selection Techniques for injection
28